MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Repros Therapeutics Company Profile (NASDAQ:RPRX)

Consensus Ratings for Repros Therapeutics (NASDAQ:RPRX) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $31.00 (309.51% upside)

Analysts' Ratings History for Repros Therapeutics (NASDAQ:RPRX)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2015LaidlawReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015Brean CapitalReiterated RatingBuy$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Brean CapitalReiterated RatingBuy$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014Piper JaffrayDowngradeOverweight -> Neutral$33.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014Ascendiant Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2013Ascendiant Capital MarketsDowngradeStrong-Buy -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2013Ladenburg ThalmannBoost Price TargetBuy$25.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013Bank of AmericaReiterated RatingBuy$25.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha